Wall Street Focuses on Banks Ahead of Fed Decision
Bloomberg Businessweek
Oversight Failures and Safety Concerns in OTC Eye Drops
This chapter highlights the failure of FDA oversight in ensuring the safety of over-the-counter eye drops, discussing cases of untested and bacteria-tainted products that caused blindness and deaths. It raises concerns about the inadequacy of FDA requirements and the manufacturing and quality issues in the pharmaceutical industry, particularly in India.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
